Skip to main content

Table 1

From: Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

Gene Symbol

Gene Title

Fold Induction

PRAME

Preferentially expressed antigen in melanoma

1.01

MAGE-A1

Melanoma antigen Family -A1

1.39

MAGE-B2

Melanoma antigen Family-B2

92.92

CTAG1A///CTAG1B

Cancer/testis antigen 1A/1B (NY-ESO-1)

376.59

MAGE-A9

Melanoma antigen Family-A9

83.45

MAGE-A4

Melanoma antigen Family-A4

248.02

CTAG1A///CTAG1B

Cancer/testis antigen 1A/1B (LAGE-2, NY-ESO-1)

57.90

CTAG2

Cancer/testis antigen-2 (LAGE-1, CAMEL)

654.87

MLANA

Melan-A/MART-1

1.86

TYR

Tyrosinase (oculocutaneous albinism 1A)

0.82

DCT

Dopachrome tautomerase (TRP-2)

0.94

MAGE-C1

Melanoma antigen Family-C1

7.03

AIM-2

Absent in melanoma-2

0.82

SILV

Silver homolog (gp100)

0.78

  1. *(log2 of normalized gene expression values)